Novel Strategies for Discovery, Validation and FDA Approval of Biomarkers for Acute and Chronic Brain Injury
None
Guardado en:
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2012
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/33549 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares: Novel Strategies for Discovery, Validation and FDA Approval of Biomarkers for Acute and Chronic Brain Injury
- Proteomic Biomarkers for the Early Detection of Acute Kidney Injury
- An FDA for AI? Pitfalls and Plausibility of Approval Regulation for Frontier Artificial Intelligence
- Tendon Injury Following Strenuous Activity: (Acute, Repetitive, and Chronic)
- Regulatory Approval Is Not Enough: Gaps in Trustworthy AI Reporting in FDA-Cleared Medical Devices
- Neutrophil Gelatinase-Associated Lipocalin as a Promising Biomarker in Acute Kidney Injury
- A Method for Characterizing Disease Progression from Acute Kidney Injury to Chronic Kidney Disease